ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

335
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
14 Dec 2022 10:32Syndicated

CX Daily: China Unplugs Travel Tracking System as Covid Curbs Ease

China unplugs travel tracking system as Covid curbs ease. Beijing beefs up health care system to handle Covid surge. China and Saudi Arabia agree...

Logo
343 Views
Share
bullishShionogi & Co
26 Nov 2022 18:11

Shionogi & Co (4507 JP): Oral COVID-19 Drug Got Approval; Files Approval for COVID-19 Vaccine

Shionogi got approval for oral COVID drug and is seeking approval for COVID-19 vaccine in Japan. The company expects ¥110 billion revenue (~27% of...

Logo
537 Views
Share
bearishPfizer Inc
09 Nov 2022 09:02

Pfizer Inc (PFE.US) - What if Pfizer Loses the China Market in the Future?

Pfizer’s China business faces challenges due to VBP/NRDL negotiation and potential further deterioration of Sino-US relations. Together with...

Logo
244 Views
Share
bullishPfizer Inc
02 Nov 2022 17:55

Pfizer Inc (PFE US): Stellar Q3 Performance; Despite Unfavorable Fx Impact, Raises 2022 Guidance

Pfizer reported beat-and-raise Q3 result. With unprecedented new launches approaching and many having blockbuster potentials, long-term growth...

Logo
279 Views
Share
26 Oct 2022 20:58

Shinpoong Pharmaceutical (019170 KS): Late Entry in COVID Drug Market; Legal Overhang Still Persists

Shinpoong will face competition from already established foreign and domestic oral COVID-19 drugs. Declining new cases are expected to keep the...

Logo
229 Views
Share
x